The Effect of Targeting the Plantaris Muscle-tendon in Surgical Correction of Ankle Equinus in Children
Plantaris Sx
1 other identifier
interventional
42
1 country
1
Brief Summary
Tight ankle muscles can produce ankle equinus (limited ability to pull the foot upward) and occur often in children, significantly impacting their ability to walk. If not treated, children with ankle equinus frequently experience reduced function and long-term foot problems, such as pain. Currently, treatment options include surgery or Botulinum toxin (BoNTA) injection into the large calf muscles that point the foot downwards, aiming to reduce their tightness. However, these treatments can be less effective over time, can create prolonged calf weakness, and may require long-term bracing. Another small muscle in the leg, the plantaris, is believed to have some contribution to equinus in many children. It is sometimes included in treatment plans for equinus but its contribution is poorly understood. It is unclear whether targeting the plantaris alone could lead to better treatment of ankle equinus. Understanding the effect of treatments targeting the plantaris could help clinicians improve the management of ankle equinus. In this study, the investigators will look at the impact of surgical treatment to the plantaris in ankle equinus. The investigators hypothesize that the plantaris is a significant contributor to equinus. In this study, data will be collected from children undergoing surgical correction of ankle equinus, including lengthening of the plantaris and lengthening of the larger muscles producing equinus (the gastrocsoleus mechanism). Children will be randomly assigned to have either their plantaris or the gastrocsoleus lengthening be done first during surgery. All children will have both structures lengthened during surgery, only the order will be varied and all surgical procedures for each patient will be completed in a single setting. In both groups, maximum passive ankle dorsiflexion (upwards bend of the ankle with the knee straight) will be measured before and after each structure is lengthened. The outcome is maximum passive ankle dorsiflexion (upwards bend of the ankle) with the knee straight. The investigators expect that maximum passive ankle dorsiflexion will increase after lengthening of the plantaris. Understanding the contribution of the plantaris muscle in ankle equinus could lead to significant improvements in the treatment of children with tight ankles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2023
CompletedFirst Submitted
Initial submission to the registry
July 22, 2025
CompletedFirst Posted
Study publicly available on registry
July 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 12, 2026
March 1, 2026
3.8 years
July 22, 2025
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Maximum passive ankle dorsiflexion
Ankle dorsiflexion (unit: degree) will be measured by the surgeon with a sterile goniometer during the surgery.
Prior to skin incision
Maximum passive ankle dorsiflexion
Ankle dorsiflexion (unit: degree) will be measured by the surgeon with a sterile goniometer during the surgery.
Prior to division of first tendon/aponeurosis
Maximum passive ankle dorsiflexion
Ankle dorsiflexion (unit: degree) will be measured by the surgeon with a sterile goniometer during the surgery.
After division of first tendon/aponeurosis
Maximum passive ankle dorsiflexion
Ankle dorsiflexion (unit: degree) will be measured by the surgeon with a sterile goniometer during the surgery.
After division of second tendon/aponeurosis
Study Arms (2)
Tendoachilles (TA) lengthening or gastrocnemius (GN) recession, then Plantaris tenotomy
EXPERIMENTALParticipants undergo Tendoachilles (TA) lengthening or gastrocnemius (GN) recession surgery before Plantaris tenotomy.
Plantaris tenotomy, then Tendoachilles (TA) lengthening or gastrocnemius (GN) recession
EXPERIMENTALParticipants undergo Plantaris tenotomy surgery before Tendoachilles (TA) lengthening or gastrocnemius (GN) recession.
Interventions
Participants undergo Tendoachilles (TA) lengthening or gastrocnemius (GN) recession surgery before Plantaris tenotomy.
Participants undergo plantaris tenotomy surgery before Tendoachilles (TA) lengthening or gastrocnemius (GN) recession.
Eligibility Criteria
You may qualify if:
- Ability to provided informed consent/assent in English.
- Pediatric patients (4-17 years) who have consented for surgery for the management of equinus contracture \* (either TA lengthening or GN recession) at the Stollery Children's Hospital
- Known underlying diagnosis of any of the following: idiopathic toe walking, cerebral palsy, hereditary spastic paraparesis, traumatic brain injury, spinal cord injury/tethering, hereditary sensory-motor neuropathy, stroke
- Ability to maintain hindfoot and midfoot neutral during assessment
- Passive plantarflexion on affected side greater than 20° and greater than degree of equinus contracture.
- Note: may be isolated or in conjunction with other orthopaedic procedures; in bilateral ankle equinus procedures, data will be collected bilaterally, but included as a single participant (i.e., single randomization).
You may not qualify if:
- Unable to provide informed consent/assent in English.
- Previous surgery for equinus
- Limb deficiency on affected side
- Knee flexion contracture of greater than 5°
- Surgical intervention of the lower extremities below the affected knee in the last twelve months
- BoNTA injections below the affected knee within the last six months
- Known or suspected arthrofibrosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stollery Children's Hospital
Edmonton, Alberta, T6G2B7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sukhdeep Dulai, MD, MHSc, FRCSC
University of Alberta
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2025
First Posted
July 29, 2025
Study Start
March 13, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 12, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share